Ruxolitinib

Ruxolitinib, also known by brand names like Jakafi, is an oral medication (taken by mouth) used to manage certain blood conditions like Myelofibrosis and Polycythemia Vera. It works by targeting specific overactive signals within your cells that contribute to these conditions, helping to reduce inflammation and slow disease progression. For patients, this can mean a reduction in the size of an enlarged spleen and relief from common symptoms such as fatigue, night sweats, and itching. Understanding Ruxolitinib can help you navigate your treatment plan and manage your daily health. Here, you'll find information about how this medication works and what it means for your care.